![](/img/cover-not-exists.png)
Updated Results from a Cancer Research UK First in Man Phase I Trial of IMA950 (A NOVEL MULTI PEPTIDE VACCINE) Plus Gm-Csf in Patients with Newly Diagnosed Glioblastoma
James, A., Mulholland, P., Peoples, S., Al-Salihi, O., Twelves, C., Jefferies, S., Halford, S., Ritchie, J., Singh-Jasuja, H., Rampling, R.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)34316-7
Date:
September, 2012
File:
PDF, 53 KB
2012